Skip to main content
. Author manuscript; available in PMC: 2009 Sep 1.
Published in final edited form as: Expert Opin Drug Metab Toxicol. 2008 Sep;4(9):1153–1165. doi: 10.1517/17425255.4.9.1153

Figure 3.

Figure 3

Sensitization of U373MG cells, expressing different CEs, to CPT-11. Cells were engineered to express no exogenous CE (pIRESneo), human liver CE (hCE1), or the mutant form of this protein (hCE1m6). The IC50 values (the concentration of drug required to produce 50% growth inhibition) for each cell line are indicated.